Skip to main content
. 2016 Mar 30;352:i859. doi: 10.1136/bmj.i859

graphic file with name quob025341.f1_default.jpg

Fig 1 Cystic fibrosis transmembrane conductance regulator (CFTR) modulators and genetic therapies in development. Adapted, with permission, from the CF Foundation drug development pipeline